Medicare Part B Drug Reimbursement: Why Change A Market-Driven System That Works Well at Controlling

The Joint Select Committee on Deficit Reduction must focus on mandatory spending programs to be successful. Unfortunately, proposals to alter Medicare Part B drug reimbursement place a successful program and the patients it supports at risk and thus are not sound and sustainable reform policies that support overall debt reduction.